Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex

British Journal of Pharmacology

Volumn 138, Issue 1, 2003, Pages 91-98

  Marti, Matteo ^a   Stocchi, Sara ^a   Paganini, Francesca ^a   Mela, Flora ^a   De Risi, Carmela ^a   Calo', Girolamo ^a   Guerrini, Remo ^a   Barnes, Timothy A ^b   Lambert, David G ^b   Beani, Lorenzo ^a   Bianchi, Clementina ^a   Morari, Michele ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

5 hydroxytryptamine; F G N OFQ(1 13)NH 2; Nphe 1 N OFQ(1 13NH 2; J 113397; JTC 801; Nociceptin orphanin FQ; Noradrenaline; Release; Synaptosomes; UFP 101

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; CYCLIC AMP; FORSKOLIN; NEUROTRANSMITTER; NOCICEPTIN; NOCICEPTIN RECEPTOR; NORADRENALIN; SEROTONIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; MALE; NEOCORTEX; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SYNAPTOSOME;

ANIMALS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; NEOCORTEX; NOREPINEPHRINE; OPIOID PEPTIDES; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, PRESYNAPTIC; SEROTONIN; SYNAPTOSOMES;

EID: 12244254414     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705005     Document Type: Article

References (42)

1. BIGONI, R., CALO, G., RIZZI, A., GUERRINI, R., DE RISI, C., HASHIMOTO, Y., HASHIBA, E., LAMBERT, D.G. & REGOLI, D. (2000). In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist. Naunyn Schmiedebergs Arch. Pharmacol., 361, 565-568.
2. 1). Peptides, 21, 1147-1154.
3. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J. Med. Chem., 41, 3360-3366.
4. CALO, G., GUERRINI, R., RIZZI, A., SALVADORI, S. & REGOLI, D. (2000). Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol., 129, 1261-1283.
5. CALO, G., RIZZI, A., BIGONI, R., GUERRINI, R., SALVADORI, S. & REGOLI, D. (2002a). Pharmacological profile of nociceptin/ orphanin FQ receptors. Clin. Exp. Pharmacol. Physiol., 29, 223-228.
6. 2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br. J. Pharmacol., 136, 303-311.
7. CAMARDA, V., RIZZI, A., CALO', G., WIRTH, K. & REGOLI, D. (2002). Pharmacological characterization of novel kinin B2 receptor ligands. Can. J. Physiol. Pharmacol., 80, 281-286.
8. COLLARD, K.J., CASSIDY, D.M., PYE, M.A. & TAYLOR, R.M. (1981). The stimulus-induced release of unmetabolized 5-hydroxytryptamine from superfused rat brain synaptosomes. J. Neurosci. Meth., 4, 163-179.
9. CONNOR, M., VAUGHAN, C.W., CHIENG, B. & CHRISTIE, M.J. (1996). Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurons in vitro. Br. J. Pharmacol., 119, 1614-1618.
10. 154-181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. Br. J. Pharmacol., 119, 1614-1618.
11. COX, B.M., CHAVKIN, C., CHRISTIE, M.J., CIVELLI, O., EVANS, C., HAMON, M.D., HOELLT, V., KIEFFER, B., KITCHEN, I., MCKNIGHT, A.T., MEUNIER, J.C. & PORTOGHESE, P.S. (2000). Opioid receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification. Girdlestone, D. ed. London: IUPHAR Media Ltd.
12. CURRO, D., YOO, Y.H., ANDERSON, M., SONG, I., DEL VALLE, J. & OWYANG, C. (2001). Molecular cloning of the orphanin FQ receptor gene and differential tissue expression of splice variants in the rat. Gene, 266, 139-145.
13. 3H-noradrenaline release from rat brain synaptosomes. Eur. J. Pharmacol., 60, 79-89.
14. DE RISI, C., POLLINI, P., TRAPELLA, C., PERETTO, I., RONZONI, S. & GIARDINA, G.A. (2001). A new synthetic approach to 1-[3R, 4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H- benzimidazol-2-one (J-113397), the first non-peptide ORL-1 receptor antagonist. Bioorg. Med. Chem., 9, 1871-1877.
15. EDMONDS-ALT, X.P., VILAIN, P., GOULAOUIC, P., PROIETTO, V., VAN BROECK, D., ADVENIER, C., NALINE, E., NELIAT, G., LE FUR, G. & BRELIERE, J.C. (1992). A potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptor. Life. Sci. Pharmacol. Lett., 50, PL101.
16. GUERRINI, R., CALO, G., BIGONI, R., RIZZI, A., VARANI, K., TOTH, G., GESSI, S., HASHIBA, E., HASHIMOTO, Y., LAMBERT, D.G., BOREA, P.A., TOMATIS, R., SALVADORI, S. & REGOLI, D. (2000). Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. J. Med. Chem., 43, 2805-2813.
17. GUERRINI, R., CALO, G., RIZZI, A., BIGONI, R., BIANCHI, C., SALVADORI, S. & REGOLI, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
18. JENCK, F., MOREAU, J.-L., MARTIN, J.R., KILPATRICK, G., REINSCHEID, R.K., MONSMA, F.J., NOTHAKER, H.-P. & CIVELLI, O. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioural responses to stress. Proc. Natl. Acad. Sci., 94, 14854-14858.
19. JENCK, F., WICHMANN, J., DAUTZENBERG, F.M., MOREAU, J.-L., OUAGAZZAL, A.M., MARTIN, J.R., LUNDSTROM, K., CESURA, A., POLI, S.M., ROEVER, S., KOLCZEWSI, S., ADAM, G. & KILPATRICK, G. (2000). A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci., 97, 4938-4943.
20. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPREY, P.P.A., LEFF, P. & SHANKLEY, N.P. (1995). International Union of Pharmacology Committee on receptor nomenclature and drug classification XI Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev., 47, 255-266.
21. KAPUSTA, D.R., CALO', G. & KENIGS, V.A. (2002). Peripheral administration of partial agonists of the nociceptin/orphanin FQ peptide (NOP) receptor produce water diuresis in conscious rats. In: Experimental Biology, New Orleans, USA.
22. KAWAMOTO, H., OZAKI, S., ITOH, Y., MIYAJI, M., ARAI, S., NAKASHIMA, H., KATO, OHIA, H. & IWASAWA, Y. (1999). Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[3R, 4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H- benzimidazol-2-one (J-113397). J. Med. Chem., 42, 5061-5063.
23. KENAKIN, T. (1993). Pharmacological analysis of drug-receptor interactions. Raven Press, New York, USA, pp. 323-343.
24. MATHIS, J.P., RYAN MORO, J., CHANG, A., HOM, J.S.H., SCHEINBERG, D.A. & PASTERNAK, G.W. (1997). Biochemical evidence for orphanin FQ/Nociceptin receptor heterogeneity in mouse brain. Biochem. Biophys. Res. Comm., 230, 462-465.
25. MEUNIER, J.C., MOLLEREAU, C., TOLL, L., SUAUDEAU, C., MOISAND, C., ALVINERIE, P., BUTOUR, J.L., GUILLEMOT, J.C., FERRARA, P., MONSARRAT, B., MAZARGUIL, H., VASSART, G., PARMENTIER, M. & COSTENTIN, J. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
26. MOGIL, J.S. & PASTERNAK, G.W. (2001). The molecular and behavioral pharmacology of the orphanin FQ/Nociceptin peptide and receptor family. Pharmacol. Rev., 53, 381-415.
27. MORARI, M., SBRENNA, S., MARTI, M., CALIARI, C., BIANCHI, C. & BEANI, L. (1998). NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms. J. Neurochem., 71, 2006-2017.
28. 2 on rat brain noradrenaline release in vivo and in vitro. Neurosci. Lett., 303, 173-176.
29. 2 in rat brain, rat vas deferens, and CHO cells expressing recombinant human nociceptin receptors. Br. J. Pharmacol., 127, 123-130.
30. OZAKI, S., KAWAMOTO, H., ITOH, Y., MIYAJI, M., AZUMA, T., ICHIKAWA, D., NAMBU, H., IGUCHI, T., IWASAWA, Y. & OTA, H. (2000). In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist. Eur. J. Pharmacol., 402, 45-53.
31. POLIDORI, C., CALO, G., CICCOCIOPPO, R., GUERRINI, R., REGOLI, D. & MASSI, M. (2000). Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology, 148, 430-437.
32. RAITERI, L. & RAITERI, M. (2000). Synaptosomes still viable after 25 years of superfusion. Neurochem. Res., 25, 1265-1274.
33. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., ARDATI, A., HENNINGSEN, R.A., BUNZOW, J.R., GRANDY, D.K., LANGEN, H., MONSMA JR. F.J. & CIVELLI, O. (1995). Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science, 270, 792-794.
34. RIZZI, D., BIGONI, R., RIZZI, A., JENCK, F., WICHMANN, J., GUERRINI, R., REGOLI, D. & CALO, G. (2001). Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn Schmiedebergs Arch. Pharmacol., 363, 551-555.
35. ROMINGER, A., FORSTER, S., ZENTNER, J., DOOLEY, D.J., MCKNIGHT, A.T., FEUERSTEIN, T.J., JACKISCH, R. & VLASKOVSKA, M. (2002). Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices. Br. J. Pharmacol., 135, 800-806.
36. SBRENNA, S., MARTI, M., MORARI, M., CALO, G., GUERRINI, R., BEANI, L. & BIANCHI, C. (2000). Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Br. J. Pharmacol., 130, 425-433.
37. SCHLICKER, E. & MORARI, M. (2000). Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides, 21, 1023-1029.
38. SHINKAI, H., ITO, T., IIDA, T., KITAO, Y., YAMADA, H. & UCHIDA, I. (2000). 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity. J. Med. Chem., 43, 4667-4677.
39. 3H]-5HT release from rat cerebral cortex slices. Br. J. Pharmacol., 128, 119-123.
40. SINISCALCHI, A., RODI, D., MORARI, M., MARTI, M., CAVALLINI, S., MARINO, S., BEANI, L. & BIANCHI, C. (2002). Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro. Br. J. Pharmacol., 136, 1178-1184.
41. VAUGHAN, C.W. & CHRISTIE, M.J. (1996). Increase by the ORL1 (opioid receptor-like 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol., 117, 1609-1611.
42. 1) receptor antagonist, JTC-801. Br. J. Pharmacol., 135, 323-332.